tm logo

Monitor this mark

View On USPTO

VASCULAN
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 21 Feb 2024

Last Applicant/ Owned by

Cumberland Pharmaceuticals Inc.

1600 West End Ave

Nashville

TN

37203

Serial Number

86880530 filed on 20th Jan 2016

Registration Number

5281997 registered on 05th Sep 2017

in the Principal Register

Correspondent Address

Kristina Montanaro Schrader

Kristina Montanaro Schrader Adams and Reese LLP

Suite 1400

Nashville, TN 37203

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

VASCULAN

Pharmaceutical preparations for use in patients with pulmonary hypertension and in patients with Peripheral Artery Disease

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for use in patients with pulmonary hypertension and in patients with Peripheral Artery Disease

First Use Date in General

28th Jun 2017

First Use Date in Commerce

28th Jun 2017

Mark Details

Serial Number

No 86880530

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 604816-24

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
21st Feb 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
21st Feb 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
21st Feb 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05th Sep 2023TEAS SECTION 8 & 15 RECEIVED
16th Jan 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16th Jan 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
16th Jan 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16th Jan 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16th Jan 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
05th Sep 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED